These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 20479391)

  • 1. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
    Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
    J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
    Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.
    Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F
    J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
    McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
    J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
    Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
    Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
    Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
    Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
    Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F
    J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
    Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
    Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
    Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
    Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
    BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
    Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
    World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas.
    Schwer AL; Kavanagh BD; McCammon R; Gaspar LE; Kleinschmidt-De Masters BK; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1352-7. PubMed ID: 19013723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.